Next Article in Journal
Delivering of Resveratrol with Solid Lipid Nanoparticles Improved Mitochondria Activity
Previous Article in Journal
New Hierarchically Organized Systems for Delivery
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessConference Report
Sci. Pharm. 2010, 78(3), 559; (registering DOI)

Targeted PLGA-Microparticles as a Novel Concept for Treatment of Lactose Intolerance

Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Life Sciences, University of Vienna, Vienna, Austria
These authors equally contributed to this work.
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
PDF [150 KB, uploaded 29 September 2016]


Background: Lactose intolerance is the inability to metabolize lactose because of the absence of the enzyme lactase. It is estimated that 75–90% of birth lactase levels are lost by most people after weaning. [...]
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

WANG, X.; RATZINGER, G.; WIRTH, M.; GABOR, F. Targeted PLGA-Microparticles as a Novel Concept for Treatment of Lactose Intolerance. Sci. Pharm. 2010, 78, 559.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top